Moreover, hyodeoxycholic acid (HDCA or Hyo-DCA), present in high concentrations in patients with cholestasis, activates the liver-X-receptor α and β (LXRα/β, NR1H3) [35]. This evidence concerns the gene NR1H3 and cholestasis.